EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 3.0

In-vitro hemolysis and its financial impact using different blood collection systems

Janne Cadamuro, Georg Martin Fiedler, Cornelia Mrazek, Thomas Klaus Felder, Hannes Oberkofler, Ulrike Kipman, Elisabeth Haschke-Becher, Helmut Wiedemann

LaboratoriumsMedizin · 01.02.2016 · 40 (1) · 49-55

DOI: 10.1515/labmed-2015-0078 ↗

Kurz gefasst

Fachartikel in der Zeitschrift LaboratoriumsMedizin, online erschienen am 06.11.2015. Verfasst von Janne Cadamuro und 7 weiteren Autor:innen. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hemolytic specimens are among the most challenging preanalytical issues in laboratory diagnostics. The type of blood collection tube in use is claimed to influence in vitro hemolysis. We aimed to examine this hypothesis and estimate the respective financial impact, evaluating routine blood samples from the past 4 years.

Methods

A total of 47,820 hemolysis index (HI) values from five different time intervals (IV1–IV5) were compared against each other, representing the following tubes: IV1-Sarstedt Monovette; IV2-8 mL/16×100 mm Greiner BioOne (GBO) Vacuette; IV3/IV4-5 mL/16×100 mm GBO Vacuette; IV5-4.5 mL/13×75 mm GBO Vacuette. For estimation of the economic impact, material, personnel and analytical costs were calculated.

Results

HI mean values in time interval IV2 were significantly higher than in all other intervals, while mean values amongst all other intervals were comparable. The number of moderately and severely hemolyzed samples increased with incrementing vacuum. Overall comparable costs between intervals IV1 and IV5 were €11,370, €14,045, €12,710, €11,213 and €8138 per 10,000 samples, respectively.

Conclusions

Aspiration tubes and low vacuum tubes show comparable hemolysis rates. Increasing vacuum levels are associated with higher hemolysis rates. By decreasing in vitro hemolysis, financial savings up to €5907 per 10,000 samples could be gained.

Zitieren

APA

Cadamuro, J., Fiedler, G. M., Mrazek, C., Felder, T. K., Oberkofler, H., Kipman, U., Haschke-Becher, E., & Wiedemann, H. (2016). In-vitro hemolysis and its financial impact using different blood collection systems. LaboratoriumsMedizin, 40(1), 49-55. https://doi.org/10.1515/labmed-2015-0078

Vancouver

Cadamuro J, Fiedler GM, Mrazek C, Felder TK, Oberkofler H, Kipman U, et al. In-vitro hemolysis and its financial impact using different blood collection systems. LaboratoriumsMedizin. 2016;40(1):49-55. doi:10.1515/labmed-2015-0078

BibTeX
@article{Cadamuro2016,
  author = {Cadamuro, Janne and Fiedler, Georg Martin and Mrazek, Cornelia and Felder, Thomas Klaus and Oberkofler, Hannes and Kipman, Ulrike and Haschke-Becher, Elisabeth and Wiedemann, Helmut},
  title = {In-vitro hemolysis and its financial impact using different blood collection systems},
  journal = {LaboratoriumsMedizin},
  year = {2016},
  volume = {40},
  number = {1},
  pages = {49--55},
  doi = {10.1515/labmed-2015-0078}
}
Kostenlos starten →